THE LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON COST BURDEN OF DRUG-RESISTANT TUBERCULOSIS IN INDIA

被引：0
|
作者：
Agnarson, M. A. [1 ]
Potluri, R. [2 ]
Bhandari, H. [3 ]
Dhir, A. [4 ]
Kumar, A. [3 ]
Gupta, V [5 ]
Raute, L. [5 ]
Shah, N. [5 ]
Kambili, C. [6 ]
Metz, L. [1 ]
机构：
[1] Johnson & Johnson, New Brunswick, NJ USA
[2] SmartAnalyst Inc, New York, NY USA
[3] SmartAnalyst India Pvt Ltd, Gurgaon, India
[4] SmartAnalyst India Pvt Ltd, Gurgaon, HR, India
[5] Janssen India, Mumbai, Maharashtra, India
[6] Johnson & Johnson, South Raritan, NJ USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN48
引用
收藏
页码：S648 / S648
页数：1
相关论文
共 50 条
  • [21] Extensively drug-resistant tuberculosis in long-term travellers
    Salzer, Helmut J. F.
    Terhalle, Elena
    Lange, Christoph
    LANCET INFECTIOUS DISEASES, 2016, 16 (06): : 642 - 643
  • [22] A cost comparison of amikacin therapy with bedaquiline, for drug-resistant tuberculosis in the UK
    Manalan, Kavina
    Green, Nathan
    Arnold, Amber
    Cooke, Graham S.
    Dedicoat, Martin
    Lipman, Marc
    Loyse, Angela
    Harrison, Tom S.
    Kon, Onn Min
    JOURNAL OF INFECTION, 2020, 80 (01) : 38 - 41
  • [23] Safety of Bedaquiline-Containing Regimens in Patients with Pulmonary Multidrug-Resistant Tuberculosis and HIV Co-Infection
    Villa, G. Castillo
    Padayatchi, N.
    Bionghi, N.
    Osman, F.
    Naidu, N.
    Master, I.
    Naidoo, K.
    Ramjee, A.
    O'Donnell, M. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [24] Clinical Outcomes Among Patients With Drug-resistant Tuberculosis Receiving Bedaquiline- or Delamanid-Containing Regimens
    Kempker, R. R.
    Mikiashvili, L.
    Zhao, Y.
    Benkeser, D.
    Barbakadze, K.
    Bablishvili, N.
    Avaliani, Z.
    Peloquin, C. A.
    Blumberg, H. M.
    Kipiani, M.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (09) : 2336 - 2344
  • [25] Early efficacy of individual regimens containing bedaquiline in patients with drug resistant tuberculosis
    Putra, Oki Nugraha
    Yulistiani, Yulistiani
    Soedarsono, Soedarsono
    Subay, Susi
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2023, 16 (04) : 169 - 175
  • [26] Early efficacy of individual regimens containing bedaquiline in patients with drug resistant tuberculosis
    Oki Nugraha Putra
    Yulistiani Yulistiani
    Soedarsono Soedarsono
    Susi Subay
    Asian Pacific Journal of Tropical Medicine, 2023, (04) : 169 - 175
  • [27] Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine
    Wallis, Robert S.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (05) : 1526 - 1527
  • [28] Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India
    Udwadia, Zarir F.
    Ganatra, Shashank
    Mullerpattan, Jai B.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
  • [29] Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa
    Olayanju, Olatunde
    Limberis, Jason
    Esmail, Aliasgar
    Oelofse, Suzette
    Gina, Phindile
    Pietersen, Elize
    Fadul, Mohammed
    Warren, Rob
    Dheda, Keertan
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (05)
  • [30] Efficacy and safety of bedaquiline containing regimens in patients of drug-resistant tuberculosis: An updated systematic review and meta-analysis
    Rehman, Obaid Ur
    Fatima, Eeshal
    Ali, Abraish
    Akram, Umar
    Nashwan, Abdulqadir
    Yunus, Faryal
    JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2024, 34
12345